Assignee
ADIMAB LLC
US·24 granted patents·18 pending applications·34 citations·filing 2013–2025
Top patents by PatentIndex Score
42 records- 0189US10189894B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2014·Granted Jan 29, 2019·6 cites·7 claims
- 0288US11312761B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Apr 26, 2022·3 cites·18 claims
- 0388US10138478B2Antibody librariesADIMAB LLC·Filed 2016·Granted Nov 27, 2018·3 cites·17 claims
- 0488US2025154687A1Antibody librariesADIMAB LLC·Filed 2024·Application pending·0 cites
- 0587US12018403B2Antibody librariesADIMAB LLC·Filed 2020·Granted Jun 25, 2024·1 cites·6 claims
- 0686US11479600B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Oct 25, 2022·2 cites·22 claims
- 0786US10196635B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2014·Granted Feb 5, 2019·4 cites·7 claims
- 0885US10889811B2Antibody librariesADIMAB LLC·Filed 2018·Granted Jan 12, 2021·1 cites·18 claims
- 0985US10329555B2High throughput generation and affinity maturation of humanized antibodyADIMAB LLC·Filed 2016·Granted Jun 25, 2019·3 cites·15 claims
- 1084US11390964B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2020·Granted Jul 19, 2022·1 cites·10 claims
- 1183US2023399386A1Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2023·Application pending·0 cites
- 1282US10787500B2Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody speciesADIMAB LLC·Filed 2016·Granted Sep 29, 2020·2 cites·22 claims
- 1381US12258679B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2022·Granted Mar 25, 2025·0 cites·16 claims
- 1481US11008383B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2018·Granted May 18, 2021·1 cites·19 claims
- 1580US11485775B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2017·Granted Nov 1, 2022·1 cites·9 claims
- 1680US11008568B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2018·Granted May 18, 2021·1 cites·17 claims
- 1780US10883997B2Polyspecificity reagents, methods for their preparation and useADIMAB LLC·Filed 2018·Granted Jan 5, 2021·1 cites·13 claims
- 1879US12281156B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2022·Granted Apr 22, 2025·0 cites·15 claims
- 1979US12215141B2Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2022·Granted Feb 4, 2025·0 cites·10 claims
- 2078US11542330B2Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2018·Granted Jan 3, 2023·1 cites·19 claims
- 2177US10156574B2Polyspecificity reagents, methods for their preparation and useADIMAB LLC·Filed 2014·Granted Dec 18, 2018·2 cites·20 claims
- 2276US10684289B2Polyclonal mixtures of antibodies, and methods of making and using themADIMAB LLC·Filed 2014·Granted Jun 16, 2020·1 cites·10 claims
- 2374US2025388653A1Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2025·Application pending·0 cites
- 2471US12181480B2Polyspecificity reagents, methods for their preparation and useADIMAB LLC·Filed 2020·Granted Dec 31, 2024·0 cites·11 claims
- 2569US2023151097A1Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and useADIMAB LLC·Filed 2022·Application pending·0 cites
- 2668US2025313612A1Anti-respiratory syncytial virus antibodies, and methods of their generation and useADIMAB LLC·Filed 2025·Application pending·0 cites
- 2768US2022396622A1Fc variants with reduced effector functionADIMAB LLC·Filed 2022·Application pending·0 cites
- 2865US12529164B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2022·Granted Jan 20, 2026·0 cites·7 claims
- 2961US2021047387A1Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody speciesADIMAB LLC·Filed 2020·Application pending·0 cites
- 3060US2021087271A1Fc variants with reduced effector functionADIMAB LLC·Filed 2020·Application pending·0 cites
- 3159US12180299B2Multispecific antibody analogs comprising a common light chain, and methods of their preparation and useADIMAB LLC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 3259US2025215082A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2023·Application pending·0 cites
- 3358US2025125011A1Systems and methods for intelligent construction of antibody librariesADIMAB LLC·Filed 2022·Application pending·0 cites
- 3455US2024228588A1Variant ch1 domains and variant cl domains engineered for preferential chain pairing and multi-specific antibodies comprising the sameADIMAB LLC·Filed 2022·Application pending·0 cites
- 3552US2022380463A1Engineered ph-dependent anti-cd3 antibodies, and methods for their generation and useADIMAB LLC·Filed 2020·Application pending·0 cites
- 3651US2024317858A1Anti-cd3 antibodiesADIMAB LLC·Filed 2022·Application pending·0 cites
- 3751US2023265134A1Ch1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the sameADIMAB LLC·Filed 2020·Application pending·0 cites
- 3849US2025019439A1Anti-idiotype antibodiesADIMAB LLC·Filed 2022·Application pending·0 cites
- 3948US12552863B2High affinity anti-CD3 antibodies, and methods for their generation and useADIMAB LLC·Filed 2020·Granted Feb 17, 2026·0 cites·19 claims
- 4047US2025223379A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2022·Application pending·0 cites
- 4146US2014377269A1Multivalent antibody analogs, and methods of their preparation and useADIMAB LLC·Filed 2013·Application pending·0 cites
- 4245US2017022291A1Multispecific antibody analogs comprising a common light chain, and methods of their preparation and useADIMAB LLC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →